Measure | Overall | Argentina | Australia | Belgium | Brazil | Canada | China | Egypt | France | Germany | India | Italy | Japan | Mexico | Pakistan | Poland | Portugal | Russia | Spain | Sweden | Switzerland | UK | USA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transparent information about WHO will benefit from the data access | 61 | 74 | 68 | 58 | 69 | 63 | 32 | 75 | 59 | 57 | 61 | 66 | 55 | 68 | 61 | 63 | 73 | 47 | 68 | 66 | 70 | 67 | 62 |
The option to withdraw your information in the future | 54 | 58 | 67 | 56 | 50 | 62 | 39 | 31 | 57 | 50 | 46 | 48 | 55 | 60 | 51 | 58 | 59 | 49 | 58 | 53 | 62 | 61 | 51 |
Knowing exactly who is using your information, and for what purpose | 53 | 56 | 61 | 61 | 52 | 56 | 46 | 45 | 53 | 63 | 40 | 45 | 56 | 57 | 47 | 52 | 60 | 62 | 52 | 53 | 63 | 53 | 45 |
Transparent information about HOW others will benefit personally, professionally and commercially from the data access | 49 | 57 | 62 | 35 | 51 | 54 | 38 | 52 | 41 | 37 | 56 | 52 | 42 | 59 | 45 | 41 | 61 | 36 | 55 | 54 | 42 | 55 | 53 |
The option to opt out of having your information accessed by other researchers | 45 | 33 | 60 | 44 | 45 | 54 | 51 | 34 | 45 | 30 | 42 | 34 | 37 | 38 | 44 | 52 | 51 | 37 | 37 | 25 | 49 | 53 | 44 |
Details about the sanctions applicable if my data is misused by others | 40 | 48 | 49 | 37 | 36 | 42 | 28 | 44 | 36 | 43 | 5 | 29 | 58 | 45 | 22 | 38 | 49 | 50 | 37 | 36 | 42 | 41 | 29 |
The ability to access your own DNA and/or medical information | 38 | 40 | 53 | 51 | 24 | 47 | 31 | 28 | 43 | 37 | 27 | 30 | 28 | 46 | 27 | 45 | 43 | 52 | 40 | 43 | 48 | 42 | 41 |
A website that clearly explains the pros and cons of data access | 37 | 38 | 49 | 32 | 35 | 40 | 38 | 38 | 28 | 29 | 56 | 29 | 36 | 35 | 42 | 31 | 27 | 28 | 29 | 30 | 33 | 46 | 49 |
Being able to communicate directly with gatekeepers of my DNA and/or medical information | 27 | 30 | 37 | 29 | 30 | 32 | 24 | 32 | 28 | 28 | 13 | 16 | 17 | 30 | 29 | 28 | 35 | 36 | 29 | 22 | 28 | 29 | 26 |
Biographies and photos of the sorts of researchers who would access the data | 21 | 21 | 17 | 14 | 21 | 20 | 34 | 28 | 19 | 15 | 31 | 13 | 24 | 28 | 23 | 17 | 16 | 20 | 19 | 14 | 13 | 15 | 23 |
Other | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 2 | 1 | 0 | 1 | 1 | 2 | 1 | 3 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 |